Dr. Irwig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-735-3322
Summary
- Dr. Michael Irwig is an endocrinologist in Boston, MA and is affiliated with Beth Israel Deaconess Medical Center. He received his medical degree from Weill Cornell Medical College of Cornell University and has been in practice 17 years. He also speaks multiple languages, including Spanish. He specializes in diabetes, gonad disorders & reproductive, and lipid metabolism.
Education & Training
- University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 2003 - 2005
- University of Virginia Medical CenterResidency, Internal Medicine, 2000 - 2003
- Weill Cornell MedicineClass of 2000
Certifications & Licensure
- MA State Medical License 2019 - 2026
- NH State Medical License 2024 - 2024
- DC State Medical License 2007 - 2020
- MD State Medical License 2005 - 2020
- WA State Medical License 2003 - 2005
- VA State Medical License 2000 - 2004
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 2 citationsThe Use of Injectable Estradiol in Transgender and Gender Diverse Adults: A Scoping Review of Dose and Serum Estradiol Levels.Micol S Rothman, Danit Ariel, Carly Kelley, Ole-Petter R Hamnvik, Jessica Abramowitz
Endocrine Practice. 2024-09-01 - Invasive Ductal Carcinoma of the Breast in a Transgender Man: A Case Report.Yujing J Heng, Kevin J Zhang, Monica G Valero, Gabrielle M Baker, Valerie J Fein-Zachary
Case Reports in Oncology. 2023-09-04 - 8 citationsLipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy.Shalem Y Leemaqz, Mabel Kyinn, Katherine Banks, Eleanor Sarkodie, Deborah Goldstein
Journal of Clinical Lipidology. 2022-11-22
Press Mentions
- Israeli Victims of Propecia Speak Out: 'I Woke up into a Nightmare'September 18th, 2022
- Use of Hair Loss Drug Propecia Can Lead to Depression, SuicideSeptember 13th, 2021
- Longest Study of Its Kind Reveals How Gender-Affirming Hormone Therapies Impact Obesity Among U.S. Transgender IndividualsAugust 19th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: